IL6 and sarcopenia: This chronic, low-grade inflammatory state is recognized as a key pathological mechanism underlying sarcopenia, where inflammatory mediators like TNF-α and IL-6, activated through the NF-κB signalling pathway, inhibit muscle protein synthesis and accelerate muscle protein breakdown (Bian et al., 2017; Xuekel et al., 2024).